Breast imaging market to exceed $1.3 billion by 2026: What is the role of 3D mammo and AI?

16th December 2022 – By Matthew Watson – in Healthcare Business News

The breast imaging market in 2022, like most healthcare technology markets, is not yet free of the turmoil induced by the COVID-19 pandemic. Backlogs in breast cancer screening and rising costs remain pressing concerns for healthcare systems around the world. Breast cancer was the most common cancer globally in 2021, accounting for 12% of all new cases, with disruptions resulting in higher proportions of women presenting cancer symptoms in advanced stages. Hence, alongside efforts to expand access to breast imaging for screening purposes, governments, particularly in developed economies, have increasingly considered prioritising higher-risk patients. Better-designed, more inclusive screening programmes are by no means the only way to address breast cancer mortality, however. Improving the accuracy of breast imaging equipment so that missed lesions and false positives are less frequent is also of central importance for healthcare providers, supporting improved treatment quality and cost-efficiency of services